NBMI Treatment in Patients With Mercury Toxicity

NCT04183595 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Mercury Poisoning

Interventions

DRUG: (N1, N3-bis(2- mercaptoethyl)isophthalamide)
OTHER: Excipients microcrystalline cellulose, silica and magnesium stearate

Sponsor

EmeraMed